Ioflupane I 123 Injection, Solution
Product Images NDC 69945-166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ioflupane I 123 (NDC 69945-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Curium Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1 (Ioflupane I 123 1)

Table 1 (Ioflupane I 123 1)
This is a table showing the absorbed dose per unit administered activity (uGy/MBaq) of various organs and tissues in the body such as adrenal, breast, stomach wall, heart wall, kidney, liver, muscle, pancreas, red marrow, spleen, and testes. The effective dose per unit administered activity (uSvIMBa) is also given as 213.*
FDA Label Image

Figure 1,2,3,4 (Ioflupane I 123 2)

Figure 1,2,3,4 (Ioflupane I 123 2)
FDA Label Image

The Following Structural Formula For Ioflupane I 123 Injection Is A Sterile, Pyrogen-free Radiopharmaceutical For Intravenous Injection. The Clear And Colorless Solution Is Supplied In Single-use Vials In Which Each Milliliter Contains 0.07 To 0.13 Mcg Ioflupane, 74 Mbq (2 Mci) Of Iodine 123 (as Ioflupane I 123) At Calibration Time, 5.7 mg Acetic Acid, 7.8 mg Sodium Acetate And 0.05 mL (5%) Ethanol. (Ioflupane I 123 3)

The Following Structural Formula For Ioflupane I 123 Injection Is A Sterile, Pyrogen-free Radiopharmaceutical For Intravenous Injection. The Clear And Colorless Solution Is Supplied In Single-use Vials In Which Each Milliliter Contains 0.07 To 0.13 Mcg Ioflupane, 74 Mbq (2 Mci) Of Iodine 123 (as Ioflupane I 123) At Calibration Time, 5.7 mg Acetic Acid, 7.8 mg Sodium Acetate And 0.05 mL (5%) Ethanol. (Ioflupane I 123 3)
FDA Label Image

R102021 Can Label (Ioflupane I 123 4)

R102021 Can Label (Ioflupane I 123 4)
This is a description of a radiopharmaceutical called loflupane 1123, available in the form of single-dose vials for intravenous administration. Loflupane 1123 is a radioactive injection with a concentration of 74 MBq/mL (2 mCi/mL). The recommended dosage of this drug is specified in the Prescribing Information. The total activity of each injection at calibration is 185 MBq (5 mCi) in a volume of 2.5 mL. The drug must be stored upright at controlled room temperature in a shielded container, and the unused portion of a single-dose vial must be discarded. The calibration date is mentioned, and it is specified that the drug expires 7 hours after calibration time. The description also includes a lot number and a manufacturer's name.*
FDA Label Image

R122021 Vial Label (Ioflupane I 123 5)

R122021 Vial Label (Ioflupane I 123 5)
This is a description of a radiopharmaceutical product labeled with a National Drug Code (NDC) 69945-166-05, provided in a single-dose vial. It contains 185 MBq (5 mCi) of loflupane | 123 at calibration, with a radioactive concentration of 74 MBq (2 mCi) per 1 mL. The product is recommended for intravenous use only and should be discarded if the unused portion is left. In addition, the product must be stored at controlled room temperature ranging from 20°C to 25°C (68°F to 77°F) upright in a shielded container to prevent radiological hazards. The volume of the product is 2.5 mL for calibration, and its shelf life expires after 7 hours of calibration time. However, the dosage of the product is not available, and the prescribing information must be consulted. The radiopharmaceutical is manufactured by Curium US LLC, and the lot number is 1234567890, with a calibration date of R12/2021.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.